Australia's largest stock trading and investment forum Australia's #1 stock forum

SPT

0.00%

7.5¢ splitit payments ltd

Spt not looking good, page-81

First 81 Last

Share
Profile

Follow
Bilbostockins

205 Posts.

12

27/08/21

22:50

Post #: 55640133
Share

Originally posted by tommyb007: ↑

Investor like you which makes SPT fail even harder. We are living in 21st century with a fast pace of payment technology. Everything should be seamless and efficient. Why do you have to make it sound so complex like working out calculus function or something. \

Example:
Customer proceeds to checkout with merchants which partnership with SPT.
- Choose SPT at checkout: customers will get the product.
- Not choosing SPT at checkout: customers will pay with their credit/debit card and they still receive the product.

Therefore, SPT makes no difference in the end to customers in terms of whether they receive the product or not. Please for godsake dont tell me that you split your balance in your account in 4 and stuff. It DOES NOT make my life easier. If I was struggling to pay something in full, I wouldnt even look at this option because it basically does not help.

I have stated on the previous post, just because your business is unique, it DOES NOT MEAN that it will work.

For those who wishy washy thinks that SPT will become $5-$10 or even $48, you can keep dreaming. You wont have to pay tax on it. On what metric do you think it deserves to get to the SP. Please dont tell me about merchant sales or addressable sales bullshit. "NPAT" is the most important figures when you look at financial position.

Also, for those dummies who said SPT will be the first to be positive in BNPL, please take a look at HUM's reports. It even pays dividends to their shareholders.

Expand

ma friend you are a fool #2. love how you both pretend to know how SPT works but have no idea. Pls sell and leave thxbye

SPT Price at posting: 46.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances